Table 1.
Relationship between NY-ESO-1 antibody positive rate and demographic features in SCLC
| Variables | NY-ESO-1Ab | P-value | |
|---|---|---|---|
|
| |||
| Positive (n) | Negative (n) | ||
| Gender | 0.371 | ||
| Male | 14 | 33 | |
| Female | 1 | 9 | |
| Age (Years) | 1.00 | ||
| > 65 | 3 | 7 | |
| ≤ 65 | 12 | 35 | |
| Smoking history daily quantity | 0.142 | ||
| > 20 | 7 | 27 | |
| ≤ 20 | 8 | 15 | |
| Time (year) | 1.00 | ||
| ≥ 20 | 11 | 30 | |
| < 20 | 4 | 2 | |
| Stage | 0.38 | ||
| LD-SCLC | 7 | 10 | |
| ED-SCLC | 8 | 32 | |
| Stage (TNM) | 0.138 | ||
| I | 5 | 6 | |
| II | 8 | 24 | |
| III | 1 | 8 | |
| IV | 1 | 4 | |
| Distant metastasis | 0.986 | ||
| Negative | 10 | 30 | |
| Positive | 5 | 12 | |